Home › NDC Lookup › RxCUI directory › RxCUI 2624735

9 HR dextroamphetamine 1 MG/HR Transdermal System [Xelstrym] — RxCUI 2624735

RxNorm drug concept · Semantic branded drug
RxCUI 2624735 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2624735
Official name9 HR dextroamphetamine 1 MG/HR Transdermal System [Xelstrym]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as9 HR Xelstrym 1 MG/HR Transdermal System; Xelstrym 9 MG in 9 HR Transdermal System; Xelstrym 9 MG per 9 HR Transdermal System
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)3,738 prescriptions · 23 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dextroamphetamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It sounds counterintuitive, but stimulants actually calm things down for many people with ADHD. Dextroamphetamine boosts dopamine and norepinephrine — two brain chemicals involved...
  • What exactly does dextroamphetamine do, and why does a stimulant help with ADHD?
  • The most common ones are decreased appetite, trouble sleeping, and headache — and decreased appetite is very common, especially early on. Taking doses too late in the day tends to...
  • What are the most common side effects I should expect?
📖 Read our full Dextroamphetamine guide →

🕸️ Concept Web — How 9 HR dextroamphetamine 1 MG/HR Transdermal Syste... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 9 HR dextroamphetamine 1 MG/HR Transdermal System [Xelstrym] RxCUI 2624735

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Dextroamphetamine 3288
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Xelstrym 2624703
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dextroamphetamine Transdermal System 2624700
    • Dextroamphetamine Topical Product 2624698
    • Dextroamphetamine Transdermal Product 2624699
    • Dextroamphetamine Transdermal System [Xelstrym] 2624707
    • Xelstrym Topical Product 2624705
    • Xelstrym Transdermal Product 2624706
    • Transdermal System 316987
    • Topical Product 1151122
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 9 HR dextroamphetamine 1 MG/HR Transdermal System SCD · 2624732
  • Dextroamphetamine 1 MG/HR SCDC · 2624731
  • Dextroamphetamine Transdermal System SCDF · 2624700
  • Dextroamphetamine Topical Product SCDG · 2624698
  • Dextroamphetamine Transdermal Product SCDG · 2624699

Brand-Name Concepts

  • Dextroamphetamine 1 MG/HR [Xelstrym] SBDC · 2624734
  • Dextroamphetamine Transdermal System [Xelstrym] SBDF · 2624707
  • Xelstrym Topical Product SBDG · 2624705
  • Xelstrym Transdermal Product SBDG · 2624706
  • Xelstrym BN · 2624703

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 2624735 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68968-0205-03 30 POUCH in 1 CARTON (68968-0205-3) / 1 PATCH, EXTENDED REL... XELSTRYM Noven Therapeutics, LLC 2023-05-15
68968-0210-03 30 POUCH in 1 CARTON (68968-0210-3) / 1 PATCH, EXTENDED REL... XELSTRYM Noven Therapeutics, LLC 2023-05-15
68968-0215-03 30 POUCH in 1 CARTON (68968-0215-3) / 1 PATCH, EXTENDED REL... XELSTRYM Noven Therapeutics, LLC 2023-05-15
68968-0220-03 30 POUCH in 1 CARTON (68968-0220-3) / 1 PATCH, EXTENDED REL... XELSTRYM Noven Therapeutics, LLC 2023-05-15
Observed labelers: Noven Therapeutics, LLC (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.